Anti-human IL22 monoclonal antibody, fezakinumab biosimilar

Home/ Products / Biosimilar Antibodies

PRODUCT

  • SKU

    DMS1108-100ug

  • Size

    100ug

  • Price

    $350

1
This antibody is part of a collection of biosimilar antibodies in reference to those approved or in clinical investigation. The biosimilars are for Research Use Only and should not be used in therapeutic or diagnostic procedures in humans or animals.
note Other commonly used names in publications refering to this antibody: ILV-094
target IL22
alias IL-22, Cytokine Zcyto18, IL-TIF
gene id Uniprot ID: Q9GZX6
host species Human
reactivity Human
iso type Human IgG1 lambda2
formulation Lyophilized from sterile PBS, pH 7.4. Typically, 5% - 8% trehalose is added as a protective agent prior to lyophilization.
reconstitution Reconstitute lyophilized powder with water to a concentration of 100 ug/ml
applications ELISA, Flow Cyt
dilution ELISA 1:5000-10000; Flow Cyt 1:100
shipping Shipped at ambient conditions.
storage Lyophilized form is stable for 1 week at room temperature. Store at -20 °C to -80 °C for 12 months in lyophilized form. After reconstitution, store at 4 °C for 2-7 days or at below -20 °C for up to 3 months.

Images

ELISA plate pre-coated by 2 ug/mL (100 uL/well) Human IL22 Protein, hFc Tag binds to Anti-IL22 Neutralizing antibody in a linear range of 2.44?625.00 ng/mL.

Flow cytometry analysis under cell membrane permeable condition with 1 ug/mL Anti-IL22 (fezakinumab biosimilar) mAb on Expi293 cells transfected with Human IL22 protein (Blue histogram) or Expi293 transfected with irrelevant protein (Red histogram).


PRODUCT

  • SKU

    DMS1108-100ug

  • Size

    100ug

  • Price

    $350

1